Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults: Program to Improve Mobility in Aging (PRIMA)

September 17, 2021 updated by: Jennifer S. Brach, University of Pittsburgh

Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults

This randomized clinical trial targets 248 community-dwelling older adults with impaired mobility (i.e. walking slowly; gait speed < 1.20 m/s). The trial compares a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training to a standard 12 week strength, endurance and flexibility program. The primary outcome is gait speed at 12 weeks. Secondary and tertiary outcomes represent components of the intervention and measures of activity and participation. Delayed and sustained effects of the intervention are examined at 24 and 36 weeks.

Study Overview

Detailed Description

Walking difficulty is common and costly in older adults. While traditional exercise has been shown to promote physical and mental health and may prevent walking difficulty, such exercise has focused on strength and endurance, and has overlooked a critical component of walking ability; the timing and coordination of movement. Aging and disease alter timing and coordination as reflected by slowed neuromotor performance, increased gait variability and reduced smoothness of movement. Task specific timing and coordination exercise that includes practice of smooth coordinated aspects of gait over multiple walking conditions has the potential to improve walking ability greater than a standard program. Our preliminary data suggest that interventions on timing and coordination of gait impact mobility greater than the standard strength and endurance program. The next key step and the objective of this proposal is to combine the two interventions to determine if potential gains in mobility, activity and participation obtained from a standard plus timing and coordination program, are larger than the gains obtained from the standard program alone. Therefore, the primary aim of the proposed project is to evaluate the impact of adding timing and coordination training to standard strength and endurance training on mobility. Secondary aims include examining 1) additional outcomes representing the components of the intervention and measures of activity and participation, 2) the delayed and sustained effects of the intervention, and 3) the effects of the intervention within various other subgroups of interest. This randomized clinical trial in 248 community-dwelling older adults who walk slowly (i.e. < 1.20 m/s) will compare a standard 12 week strength, endurance and flexibility program to a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training. The primary outcome is gait speed at 12 weeks. We will also examine secondary and tertiary outcomes representing components of the intervention and measures of activity and participation and the delayed and sustained effects at 24 and 36 weeks. The findings from this efficacy trial will provide evidence for the added value of task specific timing and coordination training for promoting walking ability in older adults and will form the basis for future effectiveness trials. Future work includes translation to nonprofessional exercise leaders with the long-term goal to incorporate neurological training into standard exercise programs for health promotion for older adults.

Study Type

Interventional

Enrollment (Actual)

353

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15219
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 65 years of age and older
  2. Ambulatory without an assistive device or the assistance of another person
  3. Usual 4 meter gait speed > 0.60 m/s and < 1.2 m/s
  4. Physician clearance to participate in a moderate intensity exercise program
  5. Not meeting physical activity recommendations defined as reporting less than 150 minutes of moderate intensity activity per week in the past month.7

Exclusion Criteria:

  1. persistent lower extremity pain that is present on most days of the week
  2. back pain that is present on most days of the weeks and interferes with walking and activities of daily living or back pain that increases with walking
  3. refuse to walk on a treadmill
  4. plans to move out of the area in the next 5 years
  5. dyspnea at rest or during activities of daily living or use supplemental oxygen (CHF, COPD)
  6. any acute illness or medical condition that is not stable according to the approving physician
  7. resting systolic blood pressure ≥ 200 mm Hg or diastolic blood pressure ≥ 100 mm Hg or resting heart rate > 100 or < 40 beats per minute
  8. diagnosed dementia or cognitive impairment defined as modified Mini-Mental State (3MS) examination <79
  9. hospitalized in the past 6 months for acute illness or surgery, other than minor surgical procedures
  10. severe visual impairment
  11. fixed or fused lower extremity joints such as hip, knee or ankle
  12. lower extremity strength <3/5 on manual muscle testing
  13. lower extremity amputation
  14. progressive movement disorder such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis or Parkinson's disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard
The standard arm consists of strength, endurance and flexibility exercises 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.
weight lifting to increase muscle strength
treadmill walking to increase endurance
stretches to improve flexibility
Intervention to encourage participants to be more physically active
Experimental: Standard-plus
The standard-plus arm consists of strength, endurance and flexibility exercises plus task specific timing and coordination exercises to improve gait 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.
weight lifting to increase muscle strength
treadmill walking to increase endurance
stretches to improve flexibility
Intervention to encourage participants to be more physically active
stepping and walking patterns to improve timing and coordination of gait

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait speed
Time Frame: 12 weeks
Usual walking speed over a short distance. A physiologic measure recorded in m/s.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoothness of walking
Time Frame: 12, 24, and 36 weeks
acceleration signal of usual walking. physiologic measure of the acceleration of walking.
12, 24, and 36 weeks
gait variability
Time Frame: 12, 24, 36 weeks
fluctuations in gait characteristics from step to step. physiologic measure of the spatial and temporal gait characteristics
12, 24, 36 weeks
Late Life Function and Disability Instrument - function subscale
Time Frame: 12, 24, and 36 weeks
Self report measure of function
12, 24, and 36 weeks
Late Life Function and Disability Instrument - disability subscale
Time Frame: 12, 24, and 36 weeks
Self report measure of disability
12, 24, and 36 weeks
Lower extremity strength
Time Frame: 12, 24, and 36 weeks
physiologic measure of leg strength
12, 24, and 36 weeks
Lower extremity muscle power
Time Frame: 12, 24, and 36 weeks
physiologic measure of leg muscle power
12, 24, and 36 weeks
Six minute walk test
Time Frame: 12, 24, and 36 weeks
physiologic measure of walking endurance
12, 24, and 36 weeks
Chair sit and reach test
Time Frame: 12, 24, and 36 weeks
physiologic measure of flexibility
12, 24, and 36 weeks
Physical activity
Time Frame: 12, 24, and 36 weeks
Physiologic measure of physical activity measured using an accelerometer.
12, 24, and 36 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported falls collected monthly by telephone
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Emergency room visits
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported emergency room visits collected monthly by telephone
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Hospital admission
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported hospital admission collected monthly by telephone
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer S Brach, PhD, PT, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

February 1, 2021

Study Registration Dates

First Submitted

January 21, 2016

First Submitted That Met QC Criteria

January 25, 2016

First Posted (Estimate)

January 26, 2016

Study Record Updates

Last Update Posted (Actual)

September 20, 2021

Last Update Submitted That Met QC Criteria

September 17, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PRO14080080

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait, Unsteady

Clinical Trials on Strength training

3
Subscribe